Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme
- PMID: 15780941
- DOI: 10.1016/j.molcel.2005.02.022
Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme
Abstract
Sir2 enzymes form a unique class of NAD(+)-dependent deacetylases required for diverse biological processes, including transcriptional silencing, regulation of apoptosis, fat mobilization, and lifespan regulation. Sir2 activity is regulated by nicotinamide, a noncompetitive inhibitor that promotes a base-exchange reaction at the expense of deacetylation. To elucidate the mechanism of nicotinamide inhibition, we determined ternary complex structures of Sir2 enzymes containing nicotinamide. The structures show that free nicotinamide binds in a conserved pocket that participates in NAD(+) binding and catalysis. Based on our structures, we engineered a mutant that deacetylates peptides by using nicotinic acid adenine dinucleotide (NAAD) as a cosubstrate and is inhibited by nicotinic acid. The characteristics of the altered specificity enzyme establish that Sir2 enzymes contain a single site that participates in catalysis and nicotinamide regulation and provides additional insights into the Sir2 catalytic mechanism.
Similar articles
-
Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.Biochemistry. 2003 Aug 12;42(31):9249-56. doi: 10.1021/bi034959l. Biochemistry. 2003. PMID: 12899610
-
Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.Biochemistry. 2004 Aug 3;43(30):9877-87. doi: 10.1021/bi049592e. Biochemistry. 2004. PMID: 15274642
-
Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8563-8. doi: 10.1073/pnas.0401057101. Epub 2004 May 18. Proc Natl Acad Sci U S A. 2004. PMID: 15150415 Free PMC article.
-
Diversity in the Sir2 family of protein deacetylases.J Leukoc Biol. 2004 Jun;75(6):939-50. doi: 10.1189/jlb.0903424. Epub 2004 Jan 23. J Leukoc Biol. 2004. PMID: 14742637 Review.
-
Quantitative assays for characterization of the Sir2 family of NAD(+)-dependent deacetylases.Methods Enzymol. 2004;376:171-87. doi: 10.1016/S0076-6879(03)76011-X. Methods Enzymol. 2004. PMID: 14975305 Review. No abstract available.
Cited by
-
Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism.Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):E2772-81. doi: 10.1073/pnas.1303628110. Epub 2013 Jul 9. Proc Natl Acad Sci U S A. 2013. PMID: 23840057 Free PMC article.
-
The role of sirtuins in Alzheimer's disease.Front Aging Neurosci. 2013 Apr 9;5:16. doi: 10.3389/fnagi.2013.00016. eCollection 2013. Front Aging Neurosci. 2013. PMID: 23576985 Free PMC article.
-
Sirt5 deacylation activities show differential sensitivities to nicotinamide inhibition.PLoS One. 2012;7(9):e45098. doi: 10.1371/journal.pone.0045098. Epub 2012 Sep 19. PLoS One. 2012. PMID: 23028781 Free PMC article.
-
Appoptosin Mediates Lesions Induced by Oxidative Stress Through the JNK-FoxO1 Pathway.Front Aging Neurosci. 2019 Sep 4;11:243. doi: 10.3389/fnagi.2019.00243. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31551758 Free PMC article.
-
SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis.Oncogene. 2019 Jan;38(3):345-359. doi: 10.1038/s41388-018-0434-6. Epub 2018 Aug 9. Oncogene. 2019. PMID: 30093629
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials